USOR 25157 - ACCELERO: Ph3 PF-08634404 (SSGJ707) in Combo With Chemo vs Bevacizumab With Chemo for Metastatic CRC

AN INTERVENTIONAL, PHASE 3, DOUBLE-BLIND, RANDOMIZED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PF-08634404 IN COMBINATION WITH CHEMOTHERAPY VERSUS BEVACIZUMAB IN COMBINATION WITH CHEMOTHERAPY IN TREATMENT-NAÏVE PARTICIPANTS WITH METASTATIC COLORECTAL CANCER

Disease Types: Colorectal

Available at: Arlington Heights, Chicago, Niles